Institutional investors purchased a net $1.9 million shares of SCLN during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 71.61% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NAVELLIER & ASSOCIATES, INC. Bought 2.6 Thousand shares of SciClone Pharmaceuticals ...
VANGUARD INVESTMENTS AUSTRALIA L... Bought 2.4 Thousand shares of SciClone Pharmaceuticals ...